BerGenBio ASA

BRRGF · OTC
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Operating Activities
Net Income-$27,070-$27,070-$28,629-$24,815
Dep. & Amort.$110$110$141$105
Deferred Tax$0$0$0$0
Stock-Based Comp.-$933-$933-$392$2,631
Change in WC-$3,187-$3,187-$4,023-$3,393
Other Non-Cash-$5,871-$5,871-$3,456-$2,100
Operating Cash Flow-$36,950-$36,950-$36,359-$27,572
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$178$178$3,440$18
Investing Cash Flow$178$178$3,440$18
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$56-$56-$20-$105
Financing Cash Flow-$56-$56-$20-$105
Forex Effect-$292-$292-$1,750$2,385
Net Chg. in Cash$0-$140,155-$34,689-$25,275
Supplemental Information
Beg. Cash$0$140,155$174,844$200,119
End Cash$0$0$140,155$174,844
Free Cash Flow-$36,950-$36,950-$36,359-$27,572
BerGenBio ASA (BRRGF) Financial Statements & Key Stats | AlphaPilot